Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model.

The cost-effectiveness of influenza vaccination for people aged 50 to 64 years: an international model. Value Health. 2007 Mar-Apr; 10(2):98-116.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.